EBITDA: Income before interest, taxes, depreciation and amortization.
International Stem Cell Corp. (ISCO) had EBITDA of $-0.05M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$9.10M |
|
$-0.42M |
|
$4.03M |
|
$5.07M |
|
$9.37M |
|
$-0.27M |
|
$-0.15M |
|
$-0.42M |
|
$-0.42M |
|
$-0.42M |
|
$-0.42M |
|
$-0.42M |
|
$-0.42M |
|
$-0.27M |
|
|
EBITDA |
$-0.05M |
8.00M |
|
8.00M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$3.41M |
|
$0.16M |
|
$1.41M |
|
$4.82M |
|
$4.58M |
|
-- |
|
$4.30M |
|
$8.88M |
|
$-4.07M |
|
$-4.70M |
|
$-4.06M |
|
8.00M |
|
| Cash Flow Statement Financials | |
$0.01M |
|
$-0.04M |
|
$-0.20M |
|
$1.23M |
|
$0.99M |
|
$-0.24M |
|
$0.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
55.68% |
|
-2.93% |
|
-2.93% |
|
-0.53% |
|
-4.59% |
|
-4.59% |
|
$-0.04M |
|
-- |
|
-- |
|
-- |
|
1.89 |
|
2.66 |
|
12.59 |
|
29.00 |
|
10.28% |
|
8.89% |
|
-8.67% |
|
10.30% |
|
$-0.51 |
|
$-0.00 |
|
$0.00 |
|